Pipeline Developer is a patent search and analysis tool that provides comprehensive patent information on molecules like liraglutide. It searches patents from major territories to identify patent families and categorize patents covering the molecule, formulations, processes, uses and combinations. The monthly updated reports are analyzed by trained staff and link to full patent documents. This allows fast analysis of the patent landscape to minimize risks for generic drug development. A single user license for the liraglutide report costs $7,200.
ISO IDMP: Practical considerations from XEVMPD experienceQdossier B.V.
ISO IDMP (Identification of Medicinal Products) is coming! What lessons can we learn from our practical exprience with XEVMPD in preparation for IDMP? Topics include data cleaning, managing inconsistencies across product registrations and countries and controlled vocabularies
After adoption and success of E2B R2 for almost a decade finally change was brought to tear down and bring some more updates to the existing ICSR Elements Design.
ISO IDMP: Practical considerations from XEVMPD experienceQdossier B.V.
ISO IDMP (Identification of Medicinal Products) is coming! What lessons can we learn from our practical exprience with XEVMPD in preparation for IDMP? Topics include data cleaning, managing inconsistencies across product registrations and countries and controlled vocabularies
After adoption and success of E2B R2 for almost a decade finally change was brought to tear down and bring some more updates to the existing ICSR Elements Design.
Replicating the FDA MAUDE DB for September 2021 in order to search MDR summaries as well as create custom insights. Required downloading files from the FDA, using python to confirm data structure, and upload to database tables. WAMP stack used to access data/provide charts.
India's Top Rated Clinical SAS training in Chennai for Pharma/ Biotech/Life Science/Clinical Research graduates. Learn how to use Clinical SAS, from beginner basics to advanced techniques, with Best Clinical SAS Training institutes in Chennai taught by industry experts. Softlogic offer unique and customized job-oriented real-world data Clinical SAS Course in Chennai from real-life patients.
http://www.softlogicsys.in/clinical-sas-training-institute-in-chennai
Incorporating Commercial and Private Data into an Open Linked Data Platform f...Alasdair Gray
The Open PHACTS Discovery Platform aims to provide an integrated information space to advance pharmacological research in the area of drug discovery. Effective drug discovery requires comprehensive data coverage, i.e. integrating all available sources of pharmacology data. While many relevant data sources are available on the linked open data cloud, their content needs to be combined with that of commercial datasets and the licensing of these commercial datasets respected when providing access to the data. Additionally, pharmaceutical companies have built up their own extensive private data collections that they require to be included in their pharmacological dataspace. In this paper we discuss the challenges of incorporating private and commercial data into a linked dataspace: focusing on the modelling of these datasets and their interlinking. We also present the graph-based access control mechanism that ensures commercial and private datasets are only available to authorized users.
http://link.springer.com/chapter/10.1007/978-3-642-41338-4_5
American CryoStem Corporation (CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today released Summary corporate and financial highlight information regarding the Company’s year ending September 30, 2016.
Data Integrity in pharmaceutical laboratories is a must, the attached ppt shall help the QC members to understand and develop an integral analytical culture
Investigating future prospects of electronic medical device labelingMyron Finseth, MSc
Examine the HL7 Structured Product Labeling (SPL) format. Better understand how: UDI data elements relate to the IFU label; and how regulated product information flows to downstream uses of SPL labeling
FDA Data Integrity: Misconceptions of 21 CFR Part 11 EduQuest, Inc.
Martin Browning, co-author of FDA's 21 CFR Part 11 regulation for electronic records and signatures, explains FDA's expectations for data integrity and common industry misconceptions about how to comply with the rule.
This white paper focuses on the 505(b)(2) New Drug Approval (NDA) regulatory pathway, which relies on the public literature of clinical studies and/or the FDA's filing of safety and efficacy data for a previously approved drug.
Data integrity - Regulatory Perspective and Challenges: santoshnarla
Data Integrity: Regulatory Perspective and Challenges.
This presentation will present the importance of data integrity in the pharma industry with regards to the quality compliance and its impact on industry. This presentation also emphasizes on importance of regulatory affairs department in ensuring the data integrity and regulatory challenges.
Data Integrity Issues in Pharmaceutical CompaniesPiyush Tripathi
Data integrity refers to maintaining and assuring the accuracy and consistency of data over its entire life-cycle, and is a critical aspect to the design, implementation and usage of any system which stores, processes, or retrieves data.
Replicating the FDA MAUDE DB for September 2021 in order to search MDR summaries as well as create custom insights. Required downloading files from the FDA, using python to confirm data structure, and upload to database tables. WAMP stack used to access data/provide charts.
India's Top Rated Clinical SAS training in Chennai for Pharma/ Biotech/Life Science/Clinical Research graduates. Learn how to use Clinical SAS, from beginner basics to advanced techniques, with Best Clinical SAS Training institutes in Chennai taught by industry experts. Softlogic offer unique and customized job-oriented real-world data Clinical SAS Course in Chennai from real-life patients.
http://www.softlogicsys.in/clinical-sas-training-institute-in-chennai
Incorporating Commercial and Private Data into an Open Linked Data Platform f...Alasdair Gray
The Open PHACTS Discovery Platform aims to provide an integrated information space to advance pharmacological research in the area of drug discovery. Effective drug discovery requires comprehensive data coverage, i.e. integrating all available sources of pharmacology data. While many relevant data sources are available on the linked open data cloud, their content needs to be combined with that of commercial datasets and the licensing of these commercial datasets respected when providing access to the data. Additionally, pharmaceutical companies have built up their own extensive private data collections that they require to be included in their pharmacological dataspace. In this paper we discuss the challenges of incorporating private and commercial data into a linked dataspace: focusing on the modelling of these datasets and their interlinking. We also present the graph-based access control mechanism that ensures commercial and private datasets are only available to authorized users.
http://link.springer.com/chapter/10.1007/978-3-642-41338-4_5
American CryoStem Corporation (CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today released Summary corporate and financial highlight information regarding the Company’s year ending September 30, 2016.
Data Integrity in pharmaceutical laboratories is a must, the attached ppt shall help the QC members to understand and develop an integral analytical culture
Investigating future prospects of electronic medical device labelingMyron Finseth, MSc
Examine the HL7 Structured Product Labeling (SPL) format. Better understand how: UDI data elements relate to the IFU label; and how regulated product information flows to downstream uses of SPL labeling
FDA Data Integrity: Misconceptions of 21 CFR Part 11 EduQuest, Inc.
Martin Browning, co-author of FDA's 21 CFR Part 11 regulation for electronic records and signatures, explains FDA's expectations for data integrity and common industry misconceptions about how to comply with the rule.
This white paper focuses on the 505(b)(2) New Drug Approval (NDA) regulatory pathway, which relies on the public literature of clinical studies and/or the FDA's filing of safety and efficacy data for a previously approved drug.
Data integrity - Regulatory Perspective and Challenges: santoshnarla
Data Integrity: Regulatory Perspective and Challenges.
This presentation will present the importance of data integrity in the pharma industry with regards to the quality compliance and its impact on industry. This presentation also emphasizes on importance of regulatory affairs department in ensuring the data integrity and regulatory challenges.
Data Integrity Issues in Pharmaceutical CompaniesPiyush Tripathi
Data integrity refers to maintaining and assuring the accuracy and consistency of data over its entire life-cycle, and is a critical aspect to the design, implementation and usage of any system which stores, processes, or retrieves data.
National Brands: Prioritizing Efforts for Scale Expion
As brands seek to obtain better returns from their social media efforts, it is critical that conversations become more relevant for the consumer. This is far easier said than done.
Altimeter’s Jeremiah Owyang discusses the challenges today and steps required to prepare for more localized engagement and activation of your entire customer facing team.
Der Weg zur ersten Million - http://internetmarketingagentur.de/ über den Vortrag von Nedim Sabic auf der SEO Campixx 2014. Der Weg zur ersten Million.
Implementing Agile in an FDA Regulated EnvironmentTechWell
Developing medical devices that are subject to FDA approval has traditionally followed the waterfall methodology, largely due to the structure of the regulations that govern development practices. But we know from myriad case studies in different industries that agile methodologies are far superior in providing the highest value to customers in the shortest time to market. Neal Herman shares how one developer of complex medical devices embraced agile software development practices and proved that it could not only develop software faster with higher quality but also meet all regulatory requirements. Convincing the internal quality management, systems engineering, and regulatory departments was difficult, but the software department was able to overcome these obstacles and fundamentally change the company’s philosophy on product development. Since 2012, software development productivity is up 100 percent, and quality is up 200 percent. Now, after seeing these gains from the software department, agile is being rolled out to all areas of R&D including hardware.
Global Manager Group provides Pre Accreditation Entry Level documentation kit for Hospital. Demo of the documentation kit described required list of mandatory documents like NABH manual, procedures, SOPs, audit checklist amd more.
For more details visit our website: https://www.globalmanagergroup.com/
Maetrics: The ROI of Good Quality & ComplianceGeneris
On October 5th, 2016 at the American Medical Device Summit in Chicago, Generis welcomed Maetrics to the speaker panel on Day One.
Ed Roach brings nearly 20 years of experience in the life sciences industry to the panel while adding his wealth of knowledge on Quality Systems and Quality Assurance, Validation, Corrective and Preventive Actions (CAPS), Root Cause Investigation, Change Management, and 483/Warning Letter Remediation to the American Medical Device Summit.
Generis is thrilled that Maetrics will be returning to Chicago for the American Medical Device Summit on October 4th and 5th in 2017.
Market Research Reports, Inc. has announced the addition of “Corneal Graft Rejection - Pipeline Insight, 2018” research report to their offering. See more at - http://mrr.cm/UWg
Market Research Reports, Inc. has announced the addition of “Acute Lung Injury - Pipeline Insight, 2018” research report to their offering. See more at - http://mrr.cm/Unn
Pharmaceutical Technology Transfer Best PracticesAnthony Grenier
Key Takeaways from the Technology Transfer Guidelines
• Standardize checklist for transferring product development, process development, and analytical method development knowledge
• Requirements are summarized in key deliverables and reports
The IPlytics Platform is an intelligence IP analytics SaaS. The IPlytics Platform uses big data frameworks to intelligently connect and analyze multiple data sources. The IPlytics Platform data sources cover over 80 million patent documents for 98 worldwide countries, over 60 million scientific articles, information regarding over 3 million companies, about 2 million standards documents from 96 standard setting organizations including over 200,000 standard essential patents (SEPs) declared at the major standard setting organizations (SSOs).
HMIRA Trade Secret Registrations in CanadaDell Tech
How to register for an exemption to disclose confidential business information otherwise required by Hazard Products Regulations (HPR) on your Safety Data Sheet (SDS) or Label.
Similar to Liraglutide - Comprehensive patent search (20)
1. Liraglutide - Comprehensive patent search
Report Details:
Published:November 2012
No. of Pages:
Price: Single User License – US$7200
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and
without the wait.
Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline
Developer minimises the risk of wasted developments or legal action, by providing you with
nothing less than the very best in comprehensive patent information. Searched and analysed by
highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer
delivers results you can rely on. And that means your staff can concentrate on how the patent
landscape affects your business, rather than trying to source reliable patent information.
Pipeline Developer features:
•Comprehensive patent searching, covering the world's key territories (see 'search coverage'
below)
•Identifies patents covering molecule, formulation, process, use, combination and assay
techniques (see 'Patent Categories Identified'below)
•Patent identification, categorisation and interpretation
•Grouped by patent family and assigned to development categories based on Interpretation of key
aspects of the patent claims
•Manual filtration of patents not relevant to generic development
•Updated on a monthly basis, including changes to patent families, statuses, and litigation
•Enables fast analysis and verification by hyper-linking to crucial patent documents and national
registers
Patent Categories Identified:
1. Molecular Form
a) Molecule Patents
b) Salts, Hydrates & Solvates
c) Polymorphic Forms
d) Other Molecular Forms
2. Active Ingredient Preparation
a) Intermediates & Preparation Thereof
b) Final Synthetic Stages
c) Complete Synthesis
d) Purification Methods
2. e) Fermentation Methods
f) Biotechnology
3. Formulations & Methods Thereof
a) General Formulations & Methods
b) Injectable Formulations
c) Oral Formulations
d) Other Administration-Specific Formulations
e) Excipients, Kits & Packaging
4. Related Medical Use & Administration
a) New Use Related to Main Indication
b) Dosing Regimen/Administration Conditions
5. Active Ingredient Combinations
a) Novel Combinations
b) Use of Combinations
c) Dosing Regimen & Administration Conditions for Combinations
6. Analytical Methods
a) Assaying Methods
b) Methods of Determining Patient Suitability
Search coverage:
Clicking on a patent family displays detailed information on the 'Core' and 'Non-Core' 'Patent
Family Equivalents'. 'Core Patent Family Equivalents' are equivalent patents from territories that
are individually verified and monitored for changes, including British, German, Spanish, French,
US, Canadian, Australian, European, and PCT patents. Statuses are also monitored and updated.
'Extended Patent Family Equivalents' are equivalent patents found through the INPADOC
database, increasing the search coverage to 70 countries.
Patent and national register access:
Clicking on a listed patent/application number or text or image link will launch a pop-up window
containing an image of the patent, enabling easy analysis of the patent documents. Clicking on a
register link launches a pop-up window with the patent office register extract for that patent. This
allows investigation into the examination status of a pending patent, opposition of a granted patent
and/or payment of maintenance fees. Please note that no extra charges apply to accessing or
downloading documents of any kind.
Litigation alerts:
Informing you of developments in court, litigation alerts can also be accessed by clicking on the
litigation symbol next to the status, with links to judgements where available.
Updating:
To take the time and hassle out of monitoring and updating a large number of patents, all Pipeline
Developer reporting is updated on a monthly basis. Convenient change flags identify new patent
families, new patent family members, changes in statuses and litigation alerts.
Legal status and transaction history:
You can also find legal status and transaction history for 'Extended Patent Family Equivalents' by
clicking on the INPADOC Family/Legal Status button for 65 additional territories.
3. Reporting and access:
All data can be exported into Microsoft Excel and print friendly versions for ease of data
manipulation and reporting. Company details are confidential and all data is SSL secure. Five
users per company are permitted and access levels are controlled by a nominated 'company
administrator'.
Pipeline Developer is just one of the benchmark products from GenericsWeb's Pipeline Patent
Intelligence product suite.
Get your copy of this report @
http://www.reportsnreports.com/reports/206873-liraglutide-comprehensive-patent-search.html
Major points covered in Table of Contents of this report include
N/A
Contact: sales@reportsandreports.com for more information.